Palliation of Brain Metastases: Factors Associated with Survival

Shoji Kutuki, Hisao Ito, Naoyuki Shigematsu, Kazuhito Toya, Wei Jai Ka, Nobuhiro Tsukamoto, Hideo Kumagaya, Minoru Uematsu, Atsushi Kubo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

One hundred ten patients with brain metastases (76 lung cancer, 11 breast cancer, 7 colorectal cancer and others) were treated with radiotherapy, and the results were retrospectively evaluated. Neurologic symptoms were improved in 66% of patients. The relationship between improvement of neurologic symptoms and several factors, including irradiation dose, primary lesion, histology, term between first treatment and recurrence, clinical symptoms and CT findings, was analyzed. There was no significant correlation between symptom relief and these factors except for the number of metastatic lesions. Four of 110 patients could survive more than 2 years after radiotherapy: one with lung cancer, one with breast cancer, one with rectum cancer and one with uterine cancer. The factors that were analyzed for symptom relief were also studied to determine their effect on the survival of lung cancer patients with brain metastases. The patients who had higher dose irradiation (50 Gy) of improvement of neurological symptoms after radiotherapy survived significantly longer than those who had 30 Gy of irradiation or no symptom relief. Multivariate analysis of these factors showed that improvement of symptoms and irradiation dose were similarly important prognostic factors, whereas the others were not correlated with survival.

Original languageEnglish
Pages (from-to)426-431
Number of pages6
JournalNippon Acta Radiologica
Volume56
Issue number6
Publication statusPublished - 1996 May

Fingerprint

Neoplasm Metastasis
Survival
Brain
Lung Neoplasms
Radiotherapy
Breast Neoplasms
Neurologic Manifestations
Uterine Neoplasms
Rectal Neoplasms
Colorectal Neoplasms
Histology
Multivariate Analysis
Recurrence
Therapeutics

Keywords

  • Brain metastasis
  • CT findings
  • Prognostic factor
  • Radiotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kutuki, S., Ito, H., Shigematsu, N., Toya, K., Ka, W. J., Tsukamoto, N., ... Kubo, A. (1996). Palliation of Brain Metastases: Factors Associated with Survival. Nippon Acta Radiologica, 56(6), 426-431.

Palliation of Brain Metastases : Factors Associated with Survival. / Kutuki, Shoji; Ito, Hisao; Shigematsu, Naoyuki; Toya, Kazuhito; Ka, Wei Jai; Tsukamoto, Nobuhiro; Kumagaya, Hideo; Uematsu, Minoru; Kubo, Atsushi.

In: Nippon Acta Radiologica, Vol. 56, No. 6, 05.1996, p. 426-431.

Research output: Contribution to journalArticle

Kutuki, S, Ito, H, Shigematsu, N, Toya, K, Ka, WJ, Tsukamoto, N, Kumagaya, H, Uematsu, M & Kubo, A 1996, 'Palliation of Brain Metastases: Factors Associated with Survival', Nippon Acta Radiologica, vol. 56, no. 6, pp. 426-431.
Kutuki S, Ito H, Shigematsu N, Toya K, Ka WJ, Tsukamoto N et al. Palliation of Brain Metastases: Factors Associated with Survival. Nippon Acta Radiologica. 1996 May;56(6):426-431.
Kutuki, Shoji ; Ito, Hisao ; Shigematsu, Naoyuki ; Toya, Kazuhito ; Ka, Wei Jai ; Tsukamoto, Nobuhiro ; Kumagaya, Hideo ; Uematsu, Minoru ; Kubo, Atsushi. / Palliation of Brain Metastases : Factors Associated with Survival. In: Nippon Acta Radiologica. 1996 ; Vol. 56, No. 6. pp. 426-431.
@article{87217b4af2c1420b91df20c05b4dc5d4,
title = "Palliation of Brain Metastases: Factors Associated with Survival",
abstract = "One hundred ten patients with brain metastases (76 lung cancer, 11 breast cancer, 7 colorectal cancer and others) were treated with radiotherapy, and the results were retrospectively evaluated. Neurologic symptoms were improved in 66{\%} of patients. The relationship between improvement of neurologic symptoms and several factors, including irradiation dose, primary lesion, histology, term between first treatment and recurrence, clinical symptoms and CT findings, was analyzed. There was no significant correlation between symptom relief and these factors except for the number of metastatic lesions. Four of 110 patients could survive more than 2 years after radiotherapy: one with lung cancer, one with breast cancer, one with rectum cancer and one with uterine cancer. The factors that were analyzed for symptom relief were also studied to determine their effect on the survival of lung cancer patients with brain metastases. The patients who had higher dose irradiation (50 Gy) of improvement of neurological symptoms after radiotherapy survived significantly longer than those who had 30 Gy of irradiation or no symptom relief. Multivariate analysis of these factors showed that improvement of symptoms and irradiation dose were similarly important prognostic factors, whereas the others were not correlated with survival.",
keywords = "Brain metastasis, CT findings, Prognostic factor, Radiotherapy",
author = "Shoji Kutuki and Hisao Ito and Naoyuki Shigematsu and Kazuhito Toya and Ka, {Wei Jai} and Nobuhiro Tsukamoto and Hideo Kumagaya and Minoru Uematsu and Atsushi Kubo",
year = "1996",
month = "5",
language = "English",
volume = "56",
pages = "426--431",
journal = "Nippon Acta Radiologica",
issn = "0048-0428",
publisher = "Japan Radiological Society",
number = "6",

}

TY - JOUR

T1 - Palliation of Brain Metastases

T2 - Factors Associated with Survival

AU - Kutuki, Shoji

AU - Ito, Hisao

AU - Shigematsu, Naoyuki

AU - Toya, Kazuhito

AU - Ka, Wei Jai

AU - Tsukamoto, Nobuhiro

AU - Kumagaya, Hideo

AU - Uematsu, Minoru

AU - Kubo, Atsushi

PY - 1996/5

Y1 - 1996/5

N2 - One hundred ten patients with brain metastases (76 lung cancer, 11 breast cancer, 7 colorectal cancer and others) were treated with radiotherapy, and the results were retrospectively evaluated. Neurologic symptoms were improved in 66% of patients. The relationship between improvement of neurologic symptoms and several factors, including irradiation dose, primary lesion, histology, term between first treatment and recurrence, clinical symptoms and CT findings, was analyzed. There was no significant correlation between symptom relief and these factors except for the number of metastatic lesions. Four of 110 patients could survive more than 2 years after radiotherapy: one with lung cancer, one with breast cancer, one with rectum cancer and one with uterine cancer. The factors that were analyzed for symptom relief were also studied to determine their effect on the survival of lung cancer patients with brain metastases. The patients who had higher dose irradiation (50 Gy) of improvement of neurological symptoms after radiotherapy survived significantly longer than those who had 30 Gy of irradiation or no symptom relief. Multivariate analysis of these factors showed that improvement of symptoms and irradiation dose were similarly important prognostic factors, whereas the others were not correlated with survival.

AB - One hundred ten patients with brain metastases (76 lung cancer, 11 breast cancer, 7 colorectal cancer and others) were treated with radiotherapy, and the results were retrospectively evaluated. Neurologic symptoms were improved in 66% of patients. The relationship between improvement of neurologic symptoms and several factors, including irradiation dose, primary lesion, histology, term between first treatment and recurrence, clinical symptoms and CT findings, was analyzed. There was no significant correlation between symptom relief and these factors except for the number of metastatic lesions. Four of 110 patients could survive more than 2 years after radiotherapy: one with lung cancer, one with breast cancer, one with rectum cancer and one with uterine cancer. The factors that were analyzed for symptom relief were also studied to determine their effect on the survival of lung cancer patients with brain metastases. The patients who had higher dose irradiation (50 Gy) of improvement of neurological symptoms after radiotherapy survived significantly longer than those who had 30 Gy of irradiation or no symptom relief. Multivariate analysis of these factors showed that improvement of symptoms and irradiation dose were similarly important prognostic factors, whereas the others were not correlated with survival.

KW - Brain metastasis

KW - CT findings

KW - Prognostic factor

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0030141332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030141332&partnerID=8YFLogxK

M3 - Article

C2 - 8710467

AN - SCOPUS:0030141332

VL - 56

SP - 426

EP - 431

JO - Nippon Acta Radiologica

JF - Nippon Acta Radiologica

SN - 0048-0428

IS - 6

ER -